当前位置:首页 - 行情中心 - 国邦医药(605507) - 财务分析

国邦医药

(605507)

  

流通市值:121.81亿  总市值:121.81亿
流通股本:7.82亿   总股本:7.82亿

国邦医药(605507)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润1.60亿元,每股收益0.29元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益871568.52万元,未分配利润428618.30万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1139579.49万元,负债268010.98万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入1,520,880,277.956,011,397,499.14,469,884,398.263,026,283,783.22
营业总成本1,334,911,518.485,101,191,544.33,740,282,795.292,520,305,808.06
其他经营收益
营业利润187,940,079.79963,993,951.63779,438,726522,095,865.12
利润总额187,173,418.77951,259,911.75774,877,685.03521,309,059.35
净利润160,128,633.56817,573,712.5667,887,425.77453,993,510.87
每股收益
其他综合收益----
综合收益总额160,128,633.56817,573,712.5667,887,425.77453,993,510.87
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计6,531,692,348.036,112,848,808.725,752,197,720.145,987,061,299.82
非流动资产:
非流动资产合计4,864,102,587.554,871,786,859.234,827,185,118.834,821,031,333.4
资产总计11,395,794,935.5810,984,635,667.9510,579,382,838.9710,808,092,633.22
流动负债:
流动负债合计2,571,091,409.771,921,262,333.751,796,077,779.642,208,722,440.65
非流动负债:
非流动负债合计109,018,372.18507,816,814.13508,029,694.74537,988,742.88
负债合计2,680,109,781.952,429,079,147.882,304,107,474.382,746,711,183.53
所有者权益(或股东权益):
归属于母公司股东权益合计8,713,753,411.688,553,123,7378,271,649,874.938,056,976,824.51
股东权益合计8,715,685,153.638,555,556,520.078,275,275,364.598,061,381,449.69
负债和股东权益合计11,395,794,935.5810,984,635,667.9510,579,382,838.9710,808,092,633.22
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,144,813,298.984,780,269,295.433,744,040,619.722,493,814,104.67
经营活动现金流出小计951,636,776.94,220,991,135.853,338,530,251.022,390,937,218.07
经营活动产生的现金流量净额193,176,522.08559,278,159.58405,510,368.7102,876,886.6
投资活动产生的现金流量:
投资活动现金流入小计3,383,229,932.4615,392,841,002.911,235,187,266.337,889,926,988.63
投资活动现金流出小计3,476,488,235.616,244,299,904.4411,747,605,860.938,117,023,257.09
投资活动产生的现金流量净额-93,258,303.14-851,458,901.54-512,418,594.6-227,096,268.46
筹资活动产生的现金流量:
筹资活动现金流入小计325,000,0001,216,605,958.45912,045,385.23846,045,385.23
筹资活动现金流出小计278,906,260.441,339,553,954.511,187,167,685.771,088,149,639.28
筹资活动产生的现金流量净额46,093,739.56-122,947,996.06-275,122,300.54-242,104,254.05
汇率变动对现金及现金等价物的影响-7,741,059.84-1,358,562.083,233,366.234,476,304.15
现金及现金等价物净增加额138,270,898.66-416,487,300.1-378,797,160.21-361,847,331.76
期末现金及现金等价物余额1,256,155,162.41,117,884,263.741,155,574,403.631,172,524,232.08
补充资料:
现金及现金等价物的净增加额--416,487,300.1--361,847,331.76
最新报告期:2026-06-03
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
首创证券王斌1.191.381.552026-06-03
招商证券侯彪,梁广楷,许菲菲1.702.252.612026-04-30
中信证券陈竹,王凯旋1.632.042.502026-04-23
西南证券徐卿,赵磐1.912.282.562026-04-20
天风证券杨松1.762.022.322026-04-19
TOP↑